Fig. 1From: The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patientsScheme of the experimental design to survey the quantitative responses of serum proteins to the two drug treatments in T2DM. X Xiaoke Pill treatment, G Glibenclamide treatment, B before drug treatment, A after drug treatment; Number 113, 114, 115, 116, 117, 118, 119, 121: iTRAQ reporterBack to article page